Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Pleural Disease
Is there any utility in using lytics for loculated malignant pleural effusion?
Answer from: at Community Practice
Yes. We frequently use tPA for loculated MPE or non-draining TPC clinically. There are many small studies on the subject with mixed results.
Sign in or Register to read more
18057
Related Questions
Do you consider discharging patients with a Heimlich valve in cases of pneumothorax with a slow persistent air leak?
Can transudative pleural effusions lead to trapped lung?
What duration of antibiotic therapy do you use for a loculated parapneumonic effusion that does not meet criteria for empyema?
Would you consider deferring chest tube placement in a clinically stable patient with a small empyema without signs of systemic infection?
What factors do you consider for patients on an individual basis when establishing a post-cardiac arrest MAP goal after ROSC is achieved, considering some may benefit from higher MAP goals for optimal cerebral perfusion?
What factors do you consider when determining whether to perform a biopsy for the diagnosis of organizing pneumonia?
Would you add abatacept to treat active inflammatory arthritis in a patient with history of RA-ILD who is already taking mycophenolate?
Have you noticed poor response to Tyvaso DPI compared to the nebulized form in PH-ILD?
Do you consider administration of nintedanib or pirfenidone via enteral tube in patients unable to take PO due to recurrent aspiration?
Do you feel high dose Symbicort or Dulera is appropriate to use for SMART despite these doses not being studied in clinical trials?